Tumor induction by simian virus 40 in mice is controlled by long-term persistence of the viral genome and the immune response of the host - PubMed (original) (raw)
Comparative Study
Tumor induction by simian virus 40 in mice is controlled by long-term persistence of the viral genome and the immune response of the host
J Abramczuk et al. J Virol. 1984 Feb.
Abstract
Simian virus 40 (SV40), which transforms mouse cells in vitro, has not been previously observed to cause tumors when injected in immunocompetent mice. We have investigated both the fate of the injected virion in mice and several immunological parameters as potential factors controlling tumorigenicity. We find that although SV40 does not replicate in mouse cells, the viral DNA can persist for many months postinjection; the majority of the viral DNA is found in the cytoplasm, but a small amount of the viral DNA is integrated at multiple sites in the host nuclear DNA. The persistence of the viral genome is independent of the ability of the mouse to mount an SV40 TSTA specific cytotoxic T-cell response and may be attributed to the cytoplasmic location of the majority of the viral genome. However, in long-term studies of SV40-injected mice, genetically identical except for the major histocompatibility complex, we find that tumors were induced in some mice of the H-2d (low cytotoxic T-lymphocyte responder to SV40 TSTA) but not of the H-2k (high responder to SV40 TSTA) haplotype. Thus, a combination of inefficient disposal of the injected virion and inefficient immunological surveillance and elimination of cells containing nuclear SV40 DNA can eventually result in SV40-induced tumors at multiple sites in mice.
Similar articles
- Immune control of SV40-induced tumors in mice.
Pan S, Abramczuk J, Knowles BB. Pan S, et al. Int J Cancer. 1987 Jun 15;39(6):722-8. doi: 10.1002/ijc.2910390612. Int J Cancer. 1987. PMID: 3034805 - Immunologic selection against simian virus-40 transformed cells: concomitnat loss of viral antigens and early viral gene sequences.
Kuster JM, Mora PT, Brown M, Khoury G. Kuster JM, et al. Proc Natl Acad Sci U S A. 1977 Nov;74(11):4796-800. doi: 10.1073/pnas.74.11.4796. Proc Natl Acad Sci U S A. 1977. PMID: 200932 Free PMC article. - Transformation by viruses: simian virus 40 as a model system.
Noonan CA, Butel JS. Noonan CA, et al. Natl Cancer Inst Monogr. 1978 May;(48):227-37. Natl Cancer Inst Monogr. 1978. PMID: 219355 Review. - Analysis of gene expression using simian virus 40 vectors.
Subramani S, Southern PJ. Subramani S, et al. Anal Biochem. 1983 Nov;135(1):1-15. doi: 10.1016/0003-2697(83)90723-6. Anal Biochem. 1983. PMID: 6322609 Review.
Cited by
- Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas.
Marton I, Johnson SE, Damjanov I, Currier KS, Sundberg JP, Knowles BB. Marton I, et al. Transgenic Res. 2000 Apr;9(2):115-25. doi: 10.1023/a:1008939620322. Transgenic Res. 2000. PMID: 10951695 - Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.
Mylin LM, Schell TD, Roberts D, Epler M, Boesteanu A, Collins EJ, Frelinger JA, Joyce S, Tevethia SS. Mylin LM, et al. J Virol. 2000 Aug;74(15):6922-34. doi: 10.1128/jvi.74.15.6922-6934.2000. J Virol. 2000. PMID: 10888631 Free PMC article. - Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X, McCarrick J, Jewett L, Knowles BB. Ye X, et al. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3916-20. doi: 10.1073/pnas.91.9.3916. Proc Natl Acad Sci U S A. 1994. PMID: 8171012 Free PMC article. - Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.
Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, Palmiter RD. Brinster RL, et al. Cell. 1984 Jun;37(2):367-79. doi: 10.1016/0092-8674(84)90367-2. Cell. 1984. PMID: 6327063 Free PMC article. - Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
Faas SJ, Pan S, Pinkert CA, Brinster RL, Knowles BB. Faas SJ, et al. J Exp Med. 1987 Feb 1;165(2):417-27. doi: 10.1084/jem.165.2.417. J Exp Med. 1987. PMID: 3029269 Free PMC article.
References
- Br J Exp Pathol. 1965 Oct;46(5):473-80 - PubMed
- Bacteriol Rev. 1964 Mar;28:30-71 - PubMed
- Biochem Biophys Res Commun. 1966 Jun 13;23(5):641-6 - PubMed
- Science. 1968 Nov 29;162(3857):1024-6 - PubMed
- J Natl Cancer Inst. 1968 Dec;41(6):1401-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources